Glucagon-like peptide-1 receptor agonists (GLP-1s) are gaining traction in both primary care and specialty settings, and for good reason
Resources We Trust Cleveland Clinic: GLP-1 Agonists Mayo Clinic: Frequently Asked Questions about Compounded Medications Obesity Medicine Association : Top Weight Loss Medications U.S
Oct 3 2005;101(1-3):319-23
Jones C
A insuficincia adrenocortical acompanhada por perda de peso, nusea, desidratao, diarreia, vmito e hipotenso
Research has characterised MT-II-induced anorexia in rodent feeding paradigms , examining food intake suppression kinetics, meal pattern changes, body weight effects with repeated administration, and the hypothalamic neurochemical changes including NPY/AgRP suppression and melanocortin pathway activation markers accompanying MT-II-induced anorexia